SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 725.62+3.0%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (2321)2/21/2018 10:03:49 PM
From: Miljenko Zuanic   of 3559
 
Thanks Ian.

Abstract is irrelevant, presentation (poster) may help evaluate candidate weight?

Point was that their IO/IO + Chemo (coping BMS Opdivo trial for 1L NSCLC) is actually a way to speed up development of in-house candidate (rising confidence level, if work). You know, Sanofi will push their own combination, as they pay more than 1/2 of expense.

PS: starting link for abstract (title) search: aacr.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News